Robert M. OʼBryan
- Oncology top 5%
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 4
- Sarcoma Diagnosis and Treatment 4
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Cancer Research top 10%
- Breast Cancer Treatment Studies 8
- Dermatology top 5%
-
- Cancer therapeutics and mechanisms 3
Robert M. OʼBryan
43 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Oncology 960
- Pulmonary and Respiratory Medicine 636
- Cardiology and Cardiovascular Medicine 349
- Cancer Research 212
- Dermatology 115
Countries citing papers authored by Robert M. OʼBryan
This map shows the geographic impact of Robert M. OʼBryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. OʼBryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. OʼBryan more than expected).
Fields of papers citing papers by Robert M. OʼBryan
This network shows the impact of papers produced by Robert M. OʼBryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. OʼBryan. The network helps show where Robert M. OʼBryan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert M. OʼBryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 53 | |
| 2 | 1995 | 25 | |
| 3 | 1993 | 16 | |
| 4 | 1993 | 40 | |
| 5 | 1988 | 14 | |
| 6 | 1987 | 70 | |
| 7 | Adjuvant therapy of breast cancer: Southwest Oncology Group studies. | 1986 | 10 |
| 8 | 1986 | 3 | |
| 9 | 1986 | 42 | |
| 10 | Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study. | 1984 | 2 |
| 11 | Cis-diamminedichloride platinum(II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study. | 1981 | 9 |
| 12 | 1980 | 1 | |
| 13 | Chemotherapy of Metastatic Renal Adenocarcinoma with a Five- Drug Regimen* | 1979 | 3 |
| 14 | Chemotherapy for metastatic osteosarcoma: studies by the M.D. Anderson Hospital and the Southwest Oncology Group | 1978 | 5 |
| 15 | 1,2:5,6-Dianhydrogalactitol in advanced breast cancer. | 1978 | 2 |
| 16 | Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine. | 1978 | 2 |
| 17 | 1977 | 5 | |
| 18 | 1977 | 300 | |
| 19 | Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. | 1976 | 114 |
| 20 | 1974 | 58 |
About Robert M. OʼBryan
Robert M. OʼBryan is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Metals and Alloys and Toxicology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (960 citations), Pulmonary and Respiratory Medicine (636 citations), Cardiology and Cardiovascular Medicine (349 citations), Cancer Research (212 citations) and Dermatology (115 citations). Robert M. OʼBryan has collaborated with scholars based in United States. Frequent co-authors include Laurence H. Baker, Jeffrey A. Gottlieb, Saul E. Rivkin, Robert W. Talley, James K. Luce, Gianni Bonadonna, Barth Hoogstraten, S P Balcerzak, Thomas E. Moon and Josh Gottlieb. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Investigational New Drugs, Radiology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.